Dr. Agarwal's Health Care Limited IPO
Witness the Dr. Agarwals Healthcare IPO spectacle, a blend of 0.75 crore freshly minted shares worth Rs 300.00 crores alongside a staggering 6.78 crore shares on sale, totaling Rs 2,727.26 crores.
The IPO opens on January 29, 2025, and closes on January 31, 2025. The price band is set at ₹382 to ₹402 per share. The minimum lot size is 35 shares.
R5
by RA ALOK DAIYA SEBI Reg. INH000011468, BSE Enlistment No. 5737
Key IPO Details
Issue Size
₹3,027.26 crores
Fresh Issue
₹300 crores
Offer for Sale
₹2,727.26 crores
Price Band
₹382 - ₹402 per share
About the Company
Dr. Agarwal's Health Care Limited offers comprehensive eye care services including cataract and refractive surgeries, consultations, diagnoses, and sale of optical products. As of September 2024, they had 737 doctors serving patients across 193 facilities in India.
Services
Cataract surgeries, refractive surgeries, retinal treatments, corneal transplants
Presence
117 cities across 14 states and 4 union territories in India
Network
28 hub facilities and 165 spoke facilities
Financial Performance
IPO Objectives
The company plans to use the net proceeds from the fresh issue for:
Debt Repayment
Repayment or prepayment of certain borrowings
General Corporate Purposes
Funding general corporate expenses
Acquisitions
Potential unidentified inorganic acquisitions
Competitive Strengths
Market Position
Largest eye care services provider in India with a trusted brand
Service Offering
Comprehensive end-to-end eye care services
Business Model
Scalable, asset-light hub-and-spoke operating model
Clinical Excellence
Strong clinical board and history of surgical innovations
Risk Factors
Valuation Concerns
IPO priced at high valuation multiples compared to peers
Market Volatility
Recent market conditions may impact listing performance
Competition
Intense competition in the eye care services sector
Regulatory Environment
Changes in healthcare regulations could affect operations
IPO Recommendation
Whether you're a conservative or risk-seeking investor, this IPO offers potential for medium to long-term gains.
Positive Factors
The company's market leadership, comprehensive service offerings, and expansion plans make it an attractive long-term prospect.
Concerns
However, the high valuation, competitive pressures, and market volatility require careful consideration of your risk tolerance and investment horizon.
We advise thoroughly reviewing the Red Herring Prospectus and consulting a financial advisor before making your investment decision.
Disclaimer: AI generated: verify independently.